2 курс / Гистология / Востриков_В_М_Олигодендроглия_в_мозге_человека_при_шизофрении

201

216.Konradi С, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. // Pharmacol. Ther., 2003, 97: 153-179.

217.Kreczmanski P., Heinsen H, Mantua V., Woltersdorf F., Masson Т., Ulfig N., Schmidt-Kastner R., Korr H., Steinbusch H.W., Hof P.R., Schmitz C. Stereological studies of capillary length density in the frontal cortex of schizophrenics. //Acta Neuropathol. (Berl), 2005, 109: 510-518.

218.Kruger L., Maxwell D.S. Comparative fine structure of vertebrate neuroglia: Jeleosts and reptiles. // J. Сотр. Neurol., 1967, 129: 115-123.

219.Kubicki M., McCarley R., Westin C.F., Park H.J., Maier S., Kikinis

R., Jolesz F.A., Shenton M.E. A review of diffusion tensor imaging studies

in schizophrenia. // J. Psychiatr. Res., 2007, 41: 1-2, 15-30.

«220. Kubicki M., Westin C.F., Maier S.E., Frumin M., Nestor P.G., Salisbury D.F., Kikinis R., Jolesz F.A., McCarley R.W., Shenton M.E: Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. //Am. J. Psychiatiy, 2002, 159: 5, 813-820.

221.Kuloglu M., Atmaca M., Ustundag В., Canatan H., Gecici O., Tezcan E. Serum iron levels in schizophrenic patients with or without akathisia. //Eur. Neuropsychopharmacol., 2003, 13: 2, 67-71.

222.Lahti A.C., Holcomb H.H., Medoff D.R., Weiler M.A., Tamminga C.A., Carpenter W.T. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. //Am. J. Psychiatry, 2001, 158: 1797-1808.

223.Lahti A.C., Weiler M.A., Holcomb H.H., Tamminga C.A., Carpenter W.T., McMahon R. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. // Neuropsychopharmacology, 2006, 31: 221-230.

224.Larsen P.H. and Yong V.W. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. //J. Neurosci., 2004, 24: 35, 7597-7603.

202

225.Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. // Br. J. Psychiatry, 1998, 172: 110-120.

226.Lesser I.M., Mena L, Boone K.B., Miller B.L., Mehringer СМ., Wohl M. Reduction of cerebral blood flow in older depressed patients. //Arch. Gen. Psychiatry, 1994, 51:9, 677-686.

227.Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. // Trends in Neurosciences, 2001, 24: 39-47

228.Lieberman J.A., Tollefson G.D., Charles C, Zipursky R., Sharma Т., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., Tohen M. HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis. // Arch. Gen. Psychiatry, 2005, 62: 361-370.

229.Lim K.O., Helpern J.A. Neuropsychiatric applications of DTI - a review. //NMR Biomed., 2002, 15: 7-8, 587-593.

230.Ling E.A., Leblond C.P. Investigation of glial cells in semithin sections. II. Variation with age in the numbers of the various glial cell types in rat cortex and copus callosum. // J. Сотр. Neurol., 1973, 149: 73-82.

231.Linkowski P., Mendlewicz J., leclercq R., Brasseur M., Hubain P., Golstein J., Copinschi G., van Cauter. The 24-hour profile of anrenocotricotropin and Cortisol in major depressive illness. // J. Clin. Endocrinology and Metabolism, 1985, 61: 429-438.

232.Liotti M., Mayberg H.S., McGinnis S., Brannan S.L., Jerabek P. Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. // Am. J. Psychiatry, 2002, 159: 11, 1830-1840.

233.Listen C, Watts R., Tottenham N., Davidson M.C., Niogi S., Ulug A.M., Casey B.J. Frontostriatal microstructure modulates efficient recruitment of cognitive control. // Cereb. Cortex, 2006, 16: 553-560.

203

234.Lodin Z., Faltin J., Mares V. Distribution of nucleic acids in the course of ontogenetic development of the nerve cell. // Folia Morphol (Praha), 1968,16:2,171-183.

235.Ludwin S.K. The function of perineuronal satellite oligodendrocytes: an immunohistochemical study. // Neuropathol. Appl. Neurobiol., 1984, 10: 143-149.

236.MacFall J.R., Payne M.E., Provenzale J.E., Krishnan K.R.R. Medial orbital frontal lesions in late-onset depression. // Biol. Psychiatry, 2000, 49: 803-806.

237.Machado-Vieira R., Dietrich M.O., Leke R., Cereser V., Zanatto V., Karczinski F., Souza D.O., Portela L.V., Gentil V. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. //Biol. Psychiatry, 2007, 61: 142144.

238.Madhavarao C.N., Moffett J.R., Moore R.A., Viola R.E., Namboodiri M.A., Jacobowitz D.M. Immunohistochemical localization of aspartoacylase in the rat central nervous system. // J. Сотр. Neurol., 2004, 472:3,318-329.

239.Maes M., Van de Vyvere J., Vandoolaeghe E., Bril Т., Demedts P., Wauters A., Neels H. Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. // J. Affect. Disord., 1996, 40: 1-2, 23-33.

240.Mahadik S.P., Khan M.M., Evans D.R., Parikh V.V. Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. // Schizophr. Res., 2002, 58: 55-62.

241.Manji H., Duman R.S. Impairments of Neuroplasticity and Cellular Resilience in Severe Mood D isorders: Implications for the Development of Novel Therapeutics. // Psychopharmacology Bulletin, 2001, 35: 5-49.

242.Mares V., Bruckner G. Posnatal formation of non-neuronal cells in the rat occipital cerebrum: An autoradiographic study of the time and space pattern of cell division. //J. Comp.NeuroL, 1978, 177: 519-528.

204

243.Mathalon D.H., Sullivan E.V., Lim K.O., Pfefferbaum A. Progressive brain volume changes and clinical course of schizophrenia: a longitudinal magnetic resonance imaging study. // Arch. Gen. Psychiatry, 2001,58: 148-157.

244.Matute C, Domercq M., Sanchez-Gomez M.V. Glutamate-mediated glial injury: mechanisms and clinical importance. // Glia, 2006, 53: 2, 212-

245.McNamara R.K., Hahn C-G., Jandacek R., Rider Т., Tso P., Stanford K.E., Richtand N.M. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. // Biol. Psychiatry, 2007, 62: 17-24.

246.McTigue D.M., Wei P., Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. // J. Neurosci., 2001, 21: 10, 3392-3400.

247.Michel T.M., Thome J., Martin D., Nara K., Zwerina S., Tatschner Т., Weijers H.G., Koutsilieri E. Cu, Znand Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. // J. Neural. Transm., 2004, 111: 1191-1201

248.Miyakawa Т., Sumiyoshi S., Deshimaru M., Suzuki Т., Tomonari H. Electron microscopic study on schizophrenia. Mechanism of pathological changes. //Acta Neuropathologica (Berlin), 1972, 20: 67-77.

249.Montag-Sallaz M. and Montag D. Severe cognitive and motor coordination deficits in tenascin-R-deficient mice. // Genes Brain Behav., 2003,2: 1,20-31.

250.Moos Т., Oates P.S., Morgan E.H. Expression of transferrin mRNA in rat oligodendrocytes is iron-independent and changes with increasing age. //Nutr. Neurosci., 2001, 4: 15-23.

251.Moos Т., Morgan E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. // Ann. N.Y. Acad. Sci., 2004, 1012: 14-26.

205

252.Morawski M., Bruckner M.K., Riederer P., Bruckner G., Arendt T. Perineuronal nets potentially protect against oxidative stess. // Exp. Neurol, 2004, 188:309-315.

253.Nagy Z., Westerberg H., Klingberg T. Maturation of white matter is associated with the development of cognitive functions during childhood. //

J.Cogn. Neurosci., 2004, 16: 7, 1227-1233.

254.Nakamura S., Todo Т., Motoi Y., Haga S., Aizawa Т., Ueki A., Ikeda

K.Glial expresson of fibroblast growth factor-9 in rat central nervous system. // Glia, 1999, 28: 53-65.

255.Narayan S., Kass K.E., Thomas E.A. Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain. // J. Neurosci. Res., 2007, 85: 757-765.

256.Navarro A., del Valle E., Tolivia J. Differential expression of apolipoprotein D in human astroglial and oligodendroglial cells. // J. Histochem. Cytochem., 2004, 52: 1031-1036.

257.Ness J.K., Romanko M.J., Rothstein R.P., Wood T.L. Levison S.W. Perinatal hypoxia-ischemia induces apoptotic death of periventricular white matter oligodendrocyte progenitors. // Dev. Neurosci., 2001, 23: 203-208.

258.Nilsson M., Perfilieva E., Johansson U., Orwar O., Eriksson P.S. Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory. // J. Neurobiol., 1999, 39: 569-578.

259.Nobuhara K., Okugawa G., Minami Т., Takase K., Yoshida Т., Yagyu Т., Tajika A., Sugimoto Т., Tamagaki C, Ikeda K., Sawada S., Kinoshita T. Effects of electroconvulsive therapy on frontal white matter in late-life depression: a diffusion tensor imaging study. // Neuropsychobiology, 2004, 50: 48-53.

260.Noga J.T., Vladar K., Torrey E.F. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. // Psychiatry Res., 2001, 106: 25-34.

206

261.O'Kusky J., Colonnier M. Postnatal changes in the number of astrocytes, oligodendrocytes and microglia in the visual cortex (area 17) of the macaque monkey: A stereological analysis in normal and monocularly deprivated animals. // J. Сотр. Neurol., 1982, 210: 307-315.

262.Ohnuma Т., Augood S.J., Arai H., McKenna P.J., Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. // Brain Res. Mol. Brain Res., 1998, 56: 207-217.

263.Olesen P.J., Nagy Z., Westerberg H., Klingberg T. Combined analysis of DTI and fMRI data reveals a joint maturation of white and grey matter in a fronto-parietal network. // Brain Res. Cogn. Brain Res., 2003, 18: 1,48-57.

264.Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. // Proc. Natl. Acad. Sci. USA, 1998, 95: 13290-13295.

265.Pakkenberg, B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenia. // Arch. Gen. Psychiatry, 1990, 47: 1023-1028.

266.Pantelis C, Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. // Schizophr. Bull., 2005, 31: 672-696.

267.Peirce T.R., Bray N.J., Williams N.M., Norton N., Moskovina V., Preece A., Haroutunian V., Buxbaum J.D., Owen M.J., O'Donovan M.C. Convergent evidence for 2,3'-cyclic nucleotide 3' phosphodiesterase as a possible susceptibility gene for schizophrenia. // Arch. Gen. Psychiatry, 2006, .63: 18-24.

268.Pesheva P., Gloor S., Schachner M., Probstmeier R. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes

207

cell adhesion by a sulfatide-mediated mechanism. // J Neurosci., 1997, 17:

12,4642-4651.

269.Peters A., Palay S.L., Webster H.F. The fine structure of the nervous system : neurons and their supporting cells. 3rd ed. New York : Oxford University Press, 1991,494 p., ill.

270.Peters A., Sethares C. Oligodendrocytes, their progenitors and other neuronal cells in the aging primate cerebral cortex. // Cereb. Cortex, 2004, 14:995-1007.

271.Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, Mannari C, Martini C, Da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovannini L, Massimetti G, Dell'osso L. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord., 2008,

105:1-3,279-283.

272.Pierri J.N., Volk C.L., Auh S., Sampson A., Lewis D.A. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. // Arch. Gen. Psychiatry, 2001, 58: 5, 466-473.

273.Pitt D., Nagelmeier I.E., Wilson H.C., Raine C.S. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. // Neurology, 2003, 61: 8, 1113-1120.

274.Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science. 2002, 298: 5596, 1248-1251.

275.Potkin S.G., Alva G., Fleming K., Anand R., Keator D., Carreon D.,

Doo M., Jin Y., Wu J.C., Fallon J.H. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. // Am. J. Psychiatry, 2002, 159: 227-237.

276. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker SJ., Huang J.T., Griffin J.L., Wayland M., Freeman Т., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J.,

208

Torrey E.F., Bahn S. Mitochondrial dysfunction in schizophrenia: evidence

for compromised brain metabolism and oxidative stress. // Mol. Psychiatry,

2004; 9: 684-697.

277.Raabe T.D., Clive D.R., Wen D., DeVries G.H. Neonatal oligodendrocytes contain and secrete neuroregulins in vitro. // J. Neurochem., 1997, 69: 1859-1863.

278.Radewicz K., Garey L„ Gentleman S,M„ Reynolds R. Increased ELA-DR immunoreactive glia in frontal and temporal cortex of chronic schizophrenia. // .[.Neuropathology Experimental Neurology, 2000, 59: 137-150.

279.Ragland J.D., Gur R.C., Raz J., Scliroeder L., Kohler C.G., Smith R.J., Alavi A., Gur R.E. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. // Am. J. Psychiatry, 2001, 158: 1114-1125.

280.Raison C.L. and Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stressrelated disorders. //Am. J. Psychiatry, 2003, 160: 1554-1565.

281.Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex. A postmortem morphometric study of schizophrenia and Huntington disease. // Arch. Gen. Psychiatry, 1998, 55: 215-224.

282.Rajkowska-Markov G., Miguel-Hidalgo J.J., Wei J. Stockmeier C.A. Reduction in glia distinguish orbitofrontal region from dorsolateral prefrontal cortex in schizophrenia. / Soc. Neurosci. Abstr., 1999, Vol. 25, Part l,p. 818.

283.Rajkowska G., Miguel-Hidalgo J.J., Wei J. Morphometric evidence for neuronal and prefrontal cell pathology in major depression. // Biol. Psychiatry, 1999,45: 1085-1098.

209

284.Rajkowska G. Dysfunction of neural circuits involved in the pathophysiology of MDD: Postmortem studies in MDD indicate altered numbers of neurons and glial cells. // Biol. Psychiatry, 2000, 48: 766-777.

285.Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the prefrontal cortex in bipolar disorder. // Biol. Psychiatry, 2001, 49: 741-452.

286.Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., Stockmeier C. Layer-specific reduction in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. // Schizophr. Res., 2002, 57: 127-138.

287.Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. // Psychiatry Research, 2003,121: 109-122.

288.Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez Т., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus Т., Evans A. Progressive cortical change during adolescence in childhoodonset schizophrenia: a longitudinal magnetic resonance imaging study. // Arch. Gen. Psychiatry, 1999, 56: 649-654.

289.Reddy R., Keshavan M.S. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia. // Prostaglandins Leukot. Essent. Fatty Acids, 2003, 69: 6, 401-405.

290.Regenold W.T., Phatak P., Marano CM., Gearhart L., Viens C.H., Hisley K.C. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. //Psychiatry Res., 2007, 151: 179-188.

210

291.Rehn A.E., Rees S.M. Investigating the neurodevelopmental hypothesis of schizophrenia. // Clin. Exp. Pharmacol. Physiol., 2005, 32: 687-696.

292.Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., Lesch K.P. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. // Mol. Psychiatry, 2006, 11:5, 514-522.

293.Rhodes KE, Fawcett JW. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? // J. Anat., 2004, 204: 1, 33-

294.Roberts G.W., Colter N., Lofthouse R., Johnstone E.C., Crow T.J. Is there gliosis in schizophrenia? Investigation of the temporal lobe. // Biol. Psychiatry, 1987,22: 1459-1468.

295.Rosenzweig M. Brain changes in response to experience. // Sci. Amer., 1972,226:22-30.

296.Ryan M.C., Sharifi N., Conden R., Thakore J.H. Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. //Psychoneuroendocrinology, 2004, 29: 1065-1070.

297.Sanchez I., Hassinger L., Paskevich P.A., Shine H.D., Nixon R.A. Oligodendroglia regulate the regional expansion of axon calibre and local accumulation of neurofilaments during development independently of myelin formation. // J. Neurosci., 1996, 16: 5095-5105.

298.Sanchez M.M., Hearn E.F., Do D., Rilling J.K., Herndon J.G. Differential rearing affects corpus callosum size and cognitive function of rhesus monkeys. //BrainRes., 1998, 812: 1-2, 38-49.

299.Sassi R.B., Stanley J.A., Axelson D., Brambilla P., Nicoletti M.A., Keshavan M.S., Ramos R.T., Ryan N., Birmaher В., Soares J.C. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. //Am. J. Psychiatry, 2005, 162: 11, 2109-2115.

300.Scheepers F.E., Gispen de Wied Ch.C, Hulshoff H.E., van de Flier W., van der Linden J.A., Kahn R.S. The effect of clozapine on caudate